Why the study?
Elevated CA125 and NTproBNP correlate with adverse events in AHF, but their comparative and incremental prognostic usefulness needed quantification.
Does elevated CA125 add prognostic value to NTproBNP for predicting death or heart failure readmission in patients with acute heart failure?
Population
352 patients admitted for AHF
Comparison
Dichotomized CA125 and NTproBNP levels based on optimal cut-offs
Design
Prospective comparative study
Follow-up
6-month
Authors
Loading...
CA125 may enhance acute HF risk stratification beyond NTproBNP; leaves open prospective validation and therapeutic impact.
Does elevated CA125 add prognostic value to NTproBNP for predicting death or heart failure readmission in patients with acute heart failure?
CA125 provides incremental prognostic value over NTproBNP for predicting 6-month death or rehospitalization in patients with acute heart failure.
Ji et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: